<DOC>
	<DOCNO>NCT01620710</DOCNO>
	<brief_summary>This trial investigate safety feasibility hypofractionated radiotherapy ( i.e . high daily dos shorter total treatment time compare standard fractionation ) prostate bed without pelvic lymph node .</brief_summary>
	<brief_title>Safety Study Shorter ( Hypofractionated ) Radiotherapy Prostate Bed With Without Pelvic Lymph Nodes</brief_title>
	<detailed_description>While evidence safety efficacy primary hypofractionated radiotherapy prostate cancer accumulating , data postoperative hypofractionated treatment prostate bed pelvic lymph node still scarce . This phase II trial initiate investigate safety feasibility hypofractionated treatment prostate bed alone pelvic lymph node . A total 80 prostate cancer patient indication adjuvant radiotherapy enrol , 40 patient low risk lymph node involvement ( arm 1 ) another 40 patient high risk lymph node involvement ( arm 2 ) receive 54 Gy 18 fraction prostate bed . Arm 2 give 45 Gy pelvic lymph node additionally . Helical Tomotherapy daily image guidance wil use .</detailed_description>
	<criteria>resect prostate carcinoma histological grading ( Gleason Score ) status post prostatectomy pT3 carcinoma and/or R1/2 resection PSA recurrence prostatectomy ( 2 consecutive PSA rise ) PSA recurrence ≥ 1 ng/ml : CT/PET/MRI image exclude pathological lymph node Karnofksy performance score ≥ 70 % age 18 80 year arm 2 : antihormonal therapy 2 month prior radiotherapy continuation hormonal suppression radiotherapy recommend write informed consent patient 's refusal patient 's inabillity give inform consent stage IV ( distant metastasis ) lymph node involvement outside pelvis severe wound complication laparatomy arm 2 : severe lymphoedema leg , elephantiasis , postthrombotic syndrome decompensated pulmonary , cardiovascular , metabolic , hematopoetic , coagulatory renal comorbidities know malignant disease distant metastases prior pelvic irradiation participation another clinical trial might compromise result PRIAMOS trial trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>prostatectomy</keyword>
</DOC>